Bristol Myers (BMY -0.6%) is lower today after being cut to Market Perform at BMO Capital on the...

|By:, SA News Editor

Bristol Myers (BMY -0.6%) is lower today after being cut to Market Perform at BMO Capital on the back of strong competitive Hep-C data from competitor Gilead (GILD +11.5%) and Merck's (MRK +0.3%) anti-PD-1 cancer immunotherpy results.